📊 Analyst Consensus & Targets
- Analyst Rating: None
- Price Target: $291.8
- Sector: Healthcare – Medical Instruments & Supplies
💡 The Growth Thesis
None Consensus: ResMed Inc. Analysts project a 21.1% potential upside. Currently trading at a Forward P/E of 20.025173.